Key result
Severe frailty is linked to ~137% higher mortality risk in octogenarian STEMI patients.
Why the study?
Octogenarians represent a large proportion of STEMI admissions and are frequently frail, but the relationship between frailty and their short- and mid-term prognoses was unclear.
Does preadmission frailty increase the risk of mortality and non-home discharge in octogenarian patients with STEMI undergoing PCI?
Cohort (n=273)
Yes
Does preadmission frailty increase the risk of mortality and non-home discharge in octogenarian patients with STEMI undergoing PCI?
Hazard Ratio: 2.37 (95% CI 1.11–5.05)
p-value: p=0.026
Preadmission frailty, assessed by the Clinical Frailty Scale, is a strong predictor of mortality and non-home discharge in octogenarian STEMI patients undergoing PCI.
Supports frailty assessment for prognostication in octogenarian STEMI; leaves open whether it should guide PCI or discharge decisions.
BACKGROUND: Octogenarians, who are frequently frail, represent a large proportion of patients admitted for ST-segment elevation myocardial infarction (STEMI). We investigated the relationship between frailty, assessed by the Canadian Study of Health and Aging Clinical Frailty Scale (CFS), and short- and mid-term prognoses in octogenarian STEMI patients. METHODS AND RESULTS: We used a multicenter registry data of 1,301 patients with STEMI undergoing percutaneous coronary intervention (PCI) between January 2014 and December 2016. Of them, 273 were retrospectively analyzed after categorization into 3 groups based on the preadmission CFS (CFS 1-3, 140 patients; CFS 4-5, 99 patients; and CFS 6-8, 34 patients). We evaluated the influence of CFS on overall mortality at 2 years and on non-home discharge, defined as the composite of in-hospital death and new transfer to a hospital or nursing home. During the study period (median, 565 days), the overall mortality and ratio of non-home discharge increased as CFS increased. After adjustment for multivariable analysis, the severely frail continued to be significantly associated with an increased risk of overall mortality (adjusted hazard ratio 2.37; 95% confidence interval [CI] 1.11-5.05; P=0.026) and non-home discharge (adjusted odds ratio 9.50; 95% CI 3.48-25.99; P<0.001). CONCLUSIONS: Frailty, as assessed by CFS, had an influence on short- and mid-term prognoses in octogenarian patients with STEMI.
No takes yet. Share an insight, caveat, or question.
Yoshioka et al. (2019) conducted a cohort in ST-elevation myocardial infarction (STEMI) (n=273). Severe frailty (Clinical Frailty Scale 6-8) vs. Not frail (Clinical Frailty Scale 1-3) was evaluated on Overall mortality at 2 years (adjusted HR 2.37, 95% CI 1.11-5.05, p=0.026). Severe frailty was significantly associated with an increased risk of overall mortality (adjusted HR 2.37) and non-home discharge (adjusted OR 9.50) in octogenarian patients with STEMI.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: